Related Experiment Video
Updated: Apr 23, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Vulnerability to sympathetic stress does not persist in takotsubo stress cardiomyopathy
Olov Collste1, Mahbubul Alam2, Martin Sundqvist1
1Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Insights
Dobutamine stress echocardiography (DSE) did not reveal abnormal cardiac function in stable takotsubo stress cardiomyopathy (TSC) patients, suggesting sympathetic stimulation vulnerability may not persist after recovery.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Stress Testing
Background:
- Takotsubo stress cardiomyopathy (TSC) is characterized by transient left ventricular dysfunction.
- The persistence of cardiac dysfunction or altered response to stress in TSC patients post-acute phase is not fully understood.
- Assessing cardiac function during stress is crucial for understanding underlying pathophysiology.
Purpose of the Study:
- To evaluate cardiac function in stable takotsubo stress cardiomyopathy patients using dobutamine stress echocardiography (DSE).
- To determine if TSC patients exhibit persistent abnormalities or altered responses to sympathetic stimulation after recovery from the acute phase.
Main Methods:
- A case-control study involving 22 TSC patients and 22 matched controls.
- Dobutamine stress echocardiography (DSE) was performed to assess cardiac function.
- Myocardial performance index (MPI) derived from tissue Doppler imaging was used to evaluate ventricular function at rest and during DSE.
Main Results:
- TSC patients exhibited a significantly higher left ventricular MPI at rest compared to controls (0.59 vs 0.53, P=.01).
- A trend towards higher right ventricular MPI was observed in TSC patients at rest (0.47 vs 0.38, P=.08).
- No significant differences in MPI were found between TSC patients and controls during DSE.
Conclusions:
- While TSC patients show altered resting ventricular function, this difference disappears during dobutamine stress.
- The study indicates that vulnerability to sympathetic stimulation does not persist in TSC patients after the acute phase.
- DSE may not be a sensitive tool for detecting persistent functional abnormalities in stable TSC patients.
Objective:
Our objective was to investigate whether dobutamine stress echocardiography (DSE) could induce abnormal cardiac function in takotsubo stress cardiomyopathy (TSC) patients in a stable condition after the acute attack.
Methods And Results:
This was a case-control study and a substudy of the Stockholm Myocardial Infarction With Normal Coronaries (SMINC) study. Twenty-two patients with a previous episode of TSC and 22 sex- and age-matched control subjects were recruited from the SMINC study and investigated with the use of DSE. All TSC patients had a previous normal cardiovascular magnetic resonance investigation. Tissue Doppler imaging-derived time phases of the cardiac cycle were recorded to calculate myocardial performance index (MPI) to assess ventricular function. Compared with control subjects at rest, TSC patients had a slightly but significantly higher left ventricular MPI (LV-MPI; 0.53 vs 0.59; P = .01) and as a trend higher right ventricular MPI (0.38 vs 0.47; P = .08), although during DSE these variables did not differ significantly.
Conclusion:
We found no difference in standard diastolic parameters between TSC and control subjects, but a significant higher value in LV-MPI in the TSC group at rest. However, no such difference could be demonstrated during DSE between the groups, indicating that vulnerability to sympathetic stimulation does not persist in TSC patients.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Introduction to Stress and Lifestyle
Heart Failure II: Pathophysiology
Psychological Responses to Stress
Sympathetic Activation

